# Seneca Biopharma, Inc. (SNCA)

Source: https://www.quantisnow.com/company/SNCA
Generated: 2026-11-13T14:54:39.044Z

- Ticker: SNCA
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Biological Products (No Diagnostic Substances)
- IPO year: n/a

## Latest SNCA news and filings

- 2021-04-29 21:56 UTC [SEC Form 4] [SEC Form 4 filed by Williams Donald Allen](https://www.quantisnow.com/insight/sec-form-4-filed-by-williams-donald-allen-676523)
- 2021-04-29 21:55 UTC [SEC Form 4] [SEC Form 4: Trenschel Robert J. was granted 304,479 units of Common Stock](https://www.quantisnow.com/insight/sec-form-4-trenschel-robert-j-was-granted-304479-units-676519)
- 2021-04-29 21:54 UTC [SEC Form 4] [SEC Form 4 filed by Neal James R](https://www.quantisnow.com/insight/sec-form-4-filed-by-neal-james-r-676515)
- 2021-04-29 21:52 UTC [SEC Form 4] [SEC Form 4: Hallam Thomas was granted 1,592 units of Common Stock](https://www.quantisnow.com/insight/sec-form-4-hallam-thomas-was-granted-1592-units-of-676509)
- 2021-04-29 21:51 UTC [SEC Form 4] [SEC Form 4: Finley John David was granted 28,718 units of Common Stock](https://www.quantisnow.com/insight/sec-form-4-finley-john-david-was-granted-28718-units-676502)
- 2021-04-29 21:47 UTC [SEC Form 4] [SEC Form 4 filed by Diaz Stephanie](https://www.quantisnow.com/insight/sec-form-4-filed-by-diaz-stephanie-676490)
- 2021-04-29 21:46 UTC [SEC Form 4] [SEC Form 4 filed by Dawson Michael John](https://www.quantisnow.com/insight/sec-form-4-filed-by-dawson-michael-john-676488)
- 2021-04-29 21:44 UTC [SEC Form 3] [SEC Form 3 filed by Williams Donald Allen](https://www.quantisnow.com/insight/sec-form-3-filed-by-williams-donald-allen-676473)
- 2021-04-29 21:42 UTC [SEC Form 3] [SEC Form 3 filed by Trenschel Robert J.](https://www.quantisnow.com/insight/sec-form-3-filed-by-trenschel-robert-j-676456)
- 2021-04-29 21:41 UTC [SEC Form 3] [SEC Form 3 filed by Neal James R](https://www.quantisnow.com/insight/sec-form-3-filed-by-neal-james-r-676448)
- 2021-04-29 21:38 UTC [SEC Form 3] [SEC Form 3 filed by Hallam Thomas](https://www.quantisnow.com/insight/sec-form-3-filed-by-hallam-thomas-676441)
- 2021-04-29 21:37 UTC [SEC Form 3] [SEC Form 3 filed by Finley John David](https://www.quantisnow.com/insight/sec-form-3-filed-by-finley-john-david-676438)
- 2021-04-29 21:35 UTC [SEC Form 3] [SEC Form 3 filed by Diaz Stephanie](https://www.quantisnow.com/insight/sec-form-3-filed-by-diaz-stephanie-676429)
- 2021-04-29 21:32 UTC [SEC Form 3] [SEC Form 3 filed by Dawson Michael John](https://www.quantisnow.com/insight/sec-form-3-filed-by-dawson-michael-john-676419)
- 2021-04-28 20:05 UTC [SEC Form 8-K] [Seneca Biopharma, Inc. filed SEC Form 8-K: Other Events (Amendment)](https://www.quantisnow.com/insight/seneca-biopharma-inc-filed-sec-form-8-k-other-events-amendment-666967)
- 2021-04-28 12:00 UTC [SEC Form 8-K] [Seneca Biopharma, Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/seneca-biopharma-inc-filed-sec-form-8-k-regulation-fd-disclosure-663811)
- 2021-04-27 21:24 UTC [SEC Form 8-K] [Seneca Biopharma, Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/seneca-biopharma-inc-filed-sec-form-8-k-entry-into-a-661599)
- 2021-04-26 23:55 UTC [SEC Form 4] [SEC Form 4 filed by Mazzo David J](https://www.quantisnow.com/insight/sec-form-4-filed-by-mazzo-david-j-655444)
- 2021-04-26 23:53 UTC [SEC Form 4] [SEC Form 4 filed by GRAY MARY ANN](https://www.quantisnow.com/insight/sec-form-4-filed-by-gray-mary-ann-655441)
- 2021-04-26 23:52 UTC [SEC Form 4] [SEC Form 4 filed by Csimma Cristina](https://www.quantisnow.com/insight/sec-form-4-filed-by-csimma-cristina-655440)
- 2021-04-26 23:51 UTC [SEC Form 4] [SEC Form 4 filed by Wei Binxian](https://www.quantisnow.com/insight/sec-form-4-filed-by-wei-binxian-655438)
- 2021-04-26 11:00 UTC [Seneca Biopharma Announces Successful Approval of Merger with Leading Biosciences, Inc.](https://www.quantisnow.com/insight/seneca-biopharma-announces-successful-approval-of-merger-with-leading-biosciences-651029)
- 2021-04-23 21:00 UTC [SEC Form 8-K] [Seneca Biopharma, Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders (Amendment)](https://www.quantisnow.com/insight/seneca-biopharma-inc-filed-sec-form-8-k-submission-of-matters-649572)
- 2021-04-20 11:00 UTC [SEC Form 425] [SEC Form 425 filed by Seneca Biopharma, Inc.](https://www.quantisnow.com/insight/sec-form-425-filed-by-seneca-biopharma-inc-632420)
- 2021-04-20 11:00 UTC [Leading BioSciences Announces Early Efficacy Signal in Reducing Post-Surgical Adhesions in Open Label Study](https://www.quantisnow.com/insight/leading-biosciences-announces-early-efficacy-signal-in-reducing-post-surgical-adhesions-632316)
- 2021-04-19 11:00 UTC [SEC Form 425] [SEC Form 425 filed by Seneca Biopharma, Inc.](https://www.quantisnow.com/insight/sec-form-425-filed-by-seneca-biopharma-inc-627326)
- 2021-04-19 11:00 UTC [SEC Form 425] [SEC Form 425 filed by Seneca Biopharma, Inc.](https://www.quantisnow.com/insight/sec-form-425-filed-by-seneca-biopharma-inc-627325)
- 2021-04-15 20:35 UTC [SEC Form 8-K] [Seneca Biopharma, Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Other Events (Amendment)](https://www.quantisnow.com/insight/seneca-biopharma-inc-filed-sec-form-8-k-submission-of-matters-622429)
- 2021-04-13 16:47 UTC [SEC Form 425] [SEC Form 425 filed by Seneca Biopharma, Inc.](https://www.quantisnow.com/insight/sec-form-425-filed-by-seneca-biopharma-inc-613000)
- 2021-04-12 11:00 UTC [SEC Form 425] [SEC Form 425 filed by Seneca Biopharma, Inc.](https://www.quantisnow.com/insight/sec-form-425-filed-by-seneca-biopharma-inc-606553)
- 2021-04-12 11:00 UTC [SEC Form 425] [SEC Form 425 filed by Seneca Biopharma, Inc.](https://www.quantisnow.com/insight/sec-form-425-filed-by-seneca-biopharma-inc-606552)
- 2021-04-12 11:00 UTC [Seneca Biopharma, Inc. Announces (i) Voting Results from the Special Meeting of Stockholders and (ii) New Special Meeting Date of April 23, 2021](https://www.quantisnow.com/insight/seneca-biopharma-inc-announces-i-voting-results-from-the-special-606519)
- 2021-04-09 21:00 UTC [SEC Form 8-K] [Seneca Biopharma, Inc. filed SEC Form 8-K: Submission Of Matters To A Vote Of Security Holders      On April 9, 2021, Seneca Biopharma, Inc, Other Events](https://www.quantisnow.com/insight/seneca-biopharma-inc-filed-sec-form-8-k-submission-of-matters-605112)
- 2021-04-05 13:28 UTC [SEC Form 425] [SEC Form 425 filed by Seneca Biopharma, Inc.](https://www.quantisnow.com/insight/sec-form-425-filed-by-seneca-biopharma-inc-584846)
- 2021-04-02 15:35 UTC [SEC Form 425] [SEC Form 425 filed by Seneca Biopharma, Inc.](https://www.quantisnow.com/insight/sec-form-425-filed-by-seneca-biopharma-inc-581331)
- 2021-03-30 11:00 UTC [SEC Form 425] [SEC Form 425 filed by Seneca Biopharma, Inc.](https://www.quantisnow.com/insight/sec-form-425-filed-by-seneca-biopharma-inc-563940)
- 2021-03-27 00:00 UTC [SEC Form 425] [SEC Form 425 filed by Seneca Biopharma, Inc.](https://www.quantisnow.com/insight/sec-form-425-filed-by-seneca-biopharma-inc-559399)
- 2021-03-24 20:46 UTC [SEC Form 425] [SEC Form 425 filed by Seneca Biopharma, Inc.](https://www.quantisnow.com/insight/sec-form-425-filed-by-seneca-biopharma-inc-549668)
- 2021-03-24 20:45 UTC [SEC Form 8-K] [SEC Form 8-K filed by Seneca Biopharma, Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-seneca-biopharma-inc-549667)
- 2021-03-24 20:30 UTC [Seneca Announces New Special Meeting Date of April 9, 2021](https://www.quantisnow.com/insight/seneca-announces-new-special-meeting-date-of-april-9-2021-549559)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/SNCA
- Earnings history: https://www.quantisnow.com/earnings/SNCA
- Dividend history: https://www.quantisnow.com/dividends/SNCA
- Insider transactions: https://www.quantisnow.com/insiders/SNCA
- Options chain: https://www.quantisnow.com/options/SNCA
- SEC 8-K filings only: https://www.quantisnow.com/company/SNCA/8-k
- RSS and alerts for SNCA: https://www.quantisnow.com/docs/rss-feeds.md
